Takeda Pharmaceutical
Matt Collins, IV, has extensive experience in the pharmaceutical industry, currently serving as Vice President of US Contracts, Operations and Reporting at Takeda since January 2014. Previously, Matt held roles at Shire Pharmaceuticals, including Senior Director and Director of Government Pricing and Reporting, where responsibilities included contract operations and government pricing management. Prior to Shire, Matt worked at Ernst & Young as a Manager, focusing on compliance audits for pharmaceutical pricing calculations. Early in their career, Matt contributed to Merck in various analytical roles and supported clinical research at GlaxoSmithKline. Matt holds an MBA in Organizational Management from Eastern University and a Bachelor of Science in Chemical Engineering from Drexel University.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.